Your browser doesn't support javascript.
loading
Immune-related pancytopenia caused by nivolumab and ipilimumab combination therapy for unresectable melanoma of unknown primary.
Uehara, Jiro; Yoshino, Koji; Sugiyama, Eiki; Ohkuma, Kaori; Oaku, Satoe; Yamashita, Chisato; Hiura, Azusa; Fujisawa, Yasuhiro.
Afiliación
  • Uehara J; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
  • Yoshino K; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
  • Sugiyama E; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
  • Ohkuma K; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
  • Oaku S; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
  • Yamashita C; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
  • Hiura A; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
  • Fujisawa Y; Department of Dermatology, University of Tsukuba, Ibaraki, Japan.
J Dermatol ; 47(6): e237-e239, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32270507

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pancitopenia / Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Nivolumab / Inhibidores de Puntos de Control Inmunológico Límite: Aged80 / Female / Humans Idioma: En Revista: J Dermatol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pancitopenia / Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Nivolumab / Inhibidores de Puntos de Control Inmunológico Límite: Aged80 / Female / Humans Idioma: En Revista: J Dermatol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido